Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$450M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$321M |
| 3 |
Costco
COST
|
+$263M |
| 4 |
Ferrari
RACE
|
+$253M |
| 5 |
GE HealthCare
GEHC
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$998M |
| 2 |
Microsoft
MSFT
|
+$581M |
| 3 |
Apple
AAPL
|
+$553M |
| 4 |
Bank of America
BAC
|
+$301M |
| 5 |
UnitedHealth
UNH
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.46% |
| 2 | Healthcare | 13.56% |
| 3 | Financials | 11.45% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
CorMedix
CRMD
$639M
| $99.4K | ﹤0.01% |
24,016
| – | – |
|
3927
ARS Pharmaceuticals
SPRY
$606M
| $98.9K | ﹤0.01% |
15,185
| – | – |
|
|
EMAN
3928
DELISTED
eMagin Corporation
EMAN
| $98.7K | ﹤0.01% |
47,473
| – | – |
|
3929
Perspective Therapeutics
CATX
$354M
| $98.4K | ﹤0.01% |
15,424
+7,701
| +100% | +$31.4K |
|
|
IVAC
3930
DELISTED
Intevac Inc
IVAC
| $95K | ﹤0.01% |
12,962
| – | – |
|
3931
Verrica Pharmaceuticals
VRCA
$83.5M
| $95K | ﹤0.01% |
1,461
+311
| +27% | +$18.8K |
|
|
CDTX
3932
DELISTED
Cidara Therapeutics
CDTX
| $94.2K | ﹤0.01% |
+3,711
| New | +$105K |
|
3933
Cadiz
CDZI
$295M
| $94K | ﹤0.01% |
23,256
+8,806
| +61% | +$35.5K |
|
|
BGXX
3934
DELISTED
Bright Green Corporation Common Stock
BGXX
| $93.6K | ﹤0.01% |
99,449
+55,876
| +128% | +$44.7K |
|
|
SURF
3935
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $92.5K | ﹤0.01% |
132,393
| – | – |
|
3936
Baytex Energy
BTE
$3B
| $91.8K | ﹤0.01% |
+24,476
| New | +$90.6K |
|
3937
Cognyte Software
CGNT
$692M
| $90.9K | ﹤0.01% |
26,803
-260,387
| -91% | -$938K |
|
|
EAR
3938
DELISTED
Eargo, Inc. Common Stock
EAR
| $90.6K | ﹤0.01% |
19,354
-2
| -0% | -$17 |
|
3939
ClearPoint Neuro
CLPT
$470M
| $90K | ﹤0.01% |
10,662
| – | – |
|
3940
Stereotaxis
STXS
$137M
| $89.9K | ﹤0.01% |
44,091
| – | – |
|
3941
Kopin
KOPN
$898M
| $88.3K | ﹤0.01% |
81,018
| – | – |
|
|
SAND
3942
DELISTED
Sandstorm Gold
SAND
| $87.5K | ﹤0.01% |
15,063
-1,640
| -10% | -$8.97K |
|
3943
Momentus
MNTS
$92.5M
| $87.1K | ﹤0.01% |
12
| – | – |
|
3944
Innodata
INOD
$2.03B
| $86.7K | ﹤0.01% |
10,156
| – | – |
|
3945
Mistras Group
MG
$584M
| $86.1K | ﹤0.01% |
12,700
| – | – |
|
3946
Acacia Research
ACTG
$449M
| $85.9K | ﹤0.01% |
22,253
| – | – |
|
3947
Citizens
CIA
$198M
| $84.6K | ﹤0.01% |
22,799
| – | – |
|
3948
Daktronics
DAKT
$988M
| $84K | ﹤0.01% |
14,813
| – | – |
|
3949
Harmony Gold Mining
HMY
$12B
| $82.6K | ﹤0.01% |
20,148
+1,488
| +8% | +$5.3K |
|
3950
Comscore
SCOR
$91.6M
| $82.6K | ﹤0.01% |
3,356
| – | – |
|
Similar funds
Bank of New York Mellon's Q1 2023 Portfolio in Review
As of Q1 2023, Bank of New York Mellon held 4,561 positions worth $457B, up 4.4% from $438B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q1 2023 filing shows 99 new, 1,204 increased, 2,632 reduced and 170 closed positions. Its largest new stake was GE HealthCare: 3,007,926 shares worth $247M. The largest sale was Johnson & Johnson, an estimated $998M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q1 2023 buy was GE HealthCare: 3,007,926 shares worth $247M.
- Bank of New York Mellon added most to O'Reilly Automotive in Q1 2023, an estimated $450M increase.
- Bank of New York Mellon's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $998M.
- Bank of New York Mellon fully exited STORE Capital Corporation in Q1 2023, selling an estimated $109M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $457B portfolio in Q1 2023.
- Bank of New York Mellon opened 99 new positions and closed 170 in Q1 2023.
- Bank of New York Mellon's portfolio value rose 4.4% quarter-over-quarter to $457B.
Based on Bank of New York Mellon's 13F filing for Q1 2023, filed 9 May 2023.